Priority Date: 24.05.05 (US 20050683772P)

Generation and profiling of fully human HuCAL GOLD(RTM)-derived therapeutic antibodies specific for human CD38

  • Application ID: EP14164595
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
1 office
Technology Company
Employment test 1001 - 5000 employees
Company dna jones day
operating since 1893
1109.86
Headquarter in Cleveland and 38 offices
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Jones Day is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 189 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 24.05.2005 - Priority Date (US 20050683772P)
  • 05.11.2014 - Publication A1 (EP2799451)

IPC Classification